Lucid Diagnostics Inc Live Stock Price Today, Share Analysis and Chart

Name: Lucid Diagnostics Inc: Is Infosys Ltd. worth buying?
Item: Lucid Diagnostics Inc
Rating: 1.69441675
Author: Trendlyne DVM scores

about

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of dev...

1.45 0.00 (0.00%)

52.63% Gain from 52W Low

166.6K

XNAS Volume

XNAS 04 Mar, 2026 12:52 PM (EST)

Not Eligible

Expensive Valuation

1.2 / 100

Technically Moderately Bullish

66.6 / 100

1Yr Price target upside is 161%

6 analysts

Lucid Diagnostics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Lucid Diagnostics Inc Live Stock Price Today, Share Analysis and Chart

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of dev...

52.63% Gain from 52W Low

SWOT Analysis

Lucid Diagnostics Inc Live Price Chart